These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27274047)

  • 1. IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarction.
    Tejada T; Tan L; Torres RA; Calvert JW; Lambert JP; Zaidi M; Husain M; Berce MD; Naib H; Pejler G; Abrink M; Graham RM; Lefer DJ; Naqvi N; Husain A
    Proc Natl Acad Sci U S A; 2016 Jun; 113(25):6949-54. PubMed ID: 27274047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chymase, mouse mast cell protease 4, constitutes the major chymotrypsin-like activity in peritoneum and ear tissue. A role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover.
    Tchougounova E; Pejler G; Abrink M
    J Exp Med; 2003 Aug; 198(3):423-31. PubMed ID: 12900518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of cardiac insulin-like growth factor-I receptor by ACE inhibition after myocardial infarction: potential role in remodeling.
    Dean RG; Bach LA; Burrell LM
    J Histochem Cytochem; 2003 Jun; 51(6):831-9. PubMed ID: 12754294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats.
    Kanemitsu H; Takai S; Tsuneyoshi H; Nishina T; Yoshikawa K; Miyazaki M; Ikeda T; Komeda M
    Hypertens Res; 2006 Jan; 29(1):57-64. PubMed ID: 16715654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction.
    Thummasorn S; Apaijai N; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2016 Dec; 34(6):404-414. PubMed ID: 27434747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
    Santos-Gallego CG; Vahl TP; Goliasch G; Picatoste B; Arias T; Ishikawa K; Njerve IU; Sanz J; Narula J; Sengupta PP; Hajjar RJ; Fuster V; Badimon JJ
    Circulation; 2016 Mar; 133(10):954-66. PubMed ID: 26826180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-1 overexpression in cardiomyocytes diminishes ex vivo heart functional recovery after acute ischemia.
    Prêle CM; Reichelt ME; Mutsaers SE; Davies M; Delbridge LM; Headrick JP; Rosenthal N; Bogoyevitch MA; Grounds MD
    Cardiovasc Pathol; 2012; 21(1):17-27. PubMed ID: 21266309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction.
    O'Sullivan JF; Leblond AL; Kelly G; Kumar AH; Metharom P; Büneker CK; Alizadeh-Vikali N; Hristova I; Hynes BG; O'Connor R; Caplice NM
    Circ Cardiovasc Interv; 2011 Aug; 4(4):327-35. PubMed ID: 21712526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse Mast Cell Protease 4 Deletion Protects Heart Function and Survival After Permanent Myocardial Infarction.
    Houde M; Schwertani A; Touil H; Desbiens L; Sarrhini O; Lecomte R; Lepage M; Gagnon H; Takai S; Pejler G; Jacques D; Gobeil F; Day R; D'Orléans-Juste P
    Front Pharmacol; 2018; 9():868. PubMed ID: 30233357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracrine Engineering of Human Cardiac Stem Cells With Insulin-Like Growth Factor 1 Enhances Myocardial Repair.
    Jackson R; Tilokee EL; Latham N; Mount S; Rafatian G; Strydhorst J; Ye B; Boodhwani M; Chan V; Ruel M; Ruddy TD; Suuronen EJ; Stewart DJ; Davis DR
    J Am Heart Assoc; 2015 Sep; 4(9):e002104. PubMed ID: 26363004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-1 protects ischemic murine myocardium from ischemia/reperfusion associated injury.
    Davani EY; Brumme Z; Singhera GK; Côté HC; Harrigan PR; Dorscheid DR
    Crit Care; 2003 Dec; 7(6):R176-83. PubMed ID: 14624693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
    Oerlemans MI; Liu J; Arslan F; den Ouden K; van Middelaar BJ; Doevendans PA; Sluijter JP
    Basic Res Cardiol; 2012 Jul; 107(4):270. PubMed ID: 22553001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration.
    Kofidis T; de Bruin JL; Yamane T; Balsam LB; Lebl DR; Swijnenburg RJ; Tanaka M; Weissman IL; Robbins RC
    Stem Cells; 2004; 22(7):1239-45. PubMed ID: 15579642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vagus nerve stimulation initiated late during ischemia, but not reperfusion, exerts cardioprotection via amelioration of cardiac mitochondrial dysfunction.
    Shinlapawittayatorn K; Chinda K; Palee S; Surinkaew S; Kumfu S; Kumphune S; Chattipakorn S; KenKnight BH; Chattipakorn N
    Heart Rhythm; 2014 Dec; 11(12):2278-87. PubMed ID: 25093803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction.
    Chang MY; Yang YJ; Chang CH; Tang AC; Liao WY; Cheng FY; Yeh CS; Lai JJ; Stayton PS; Hsieh PC
    J Control Release; 2013 Sep; 170(2):287-94. PubMed ID: 23665256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signalling pathways in ischaemic postconditioning.
    Hausenloy DJ
    Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of vascular endothelial growth factor and receptor tyrosine kinases in cardiac ischemia/reperfusion injury.
    Infanger M; Faramarzi S; Grosse J; Kurth E; Ulbrich C; Bauer J; Wehland M; Kreutz R; Kossmehl P; Paul M; Grimm D
    Cardiovasc Pathol; 2007; 16(5):291-9. PubMed ID: 17868880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of circulating IGF-1 for normal cardiac morphology, function and post infarction remodeling.
    Scharin Täng M; Redfors B; Lindbom M; Svensson J; Ramunddal T; Ohlsson C; Shao Y; Omerovic E
    Growth Horm IGF Res; 2012 Dec; 22(6):206-11. PubMed ID: 23102937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. After Myocardial Ischemia-Reperfusion, miR-29a, and Let7 Could Affect Apoptosis through Regulating IGF-1.
    Wang L; Niu X; Hu J; Xing H; Sun M; Wang J; Jian Q; Yang H
    Biomed Res Int; 2015; 2015():245412. PubMed ID: 26844226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
    Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.